日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Estimating paediatric normative values for nerve studies using clustering techniques

利用聚类技术估计儿童神经研究的正常值

Cooray, G K; Motan, D; Howse, K; Nastasi, L; Deeb, J

Evaluating pediatric peripheral neuromuscular disorders using deep neural networks on electrodiagnostic data

利用深度神经网络对电诊断数据进行儿科周围神经肌肉疾病评估

Cooray, G K; Nastasi, L; Motan, D; Deeb, J

Hyperbaric Oxygen Therapy for Complications in Nipple-Sparing Mastectomy with Breast Reconstruction: A Systematic Review

高压氧疗法治疗保留乳头乳房切除术联合乳房重建术后并发症:系统评价

Idris, Omer A; Ahmedfiqi, Yaqub O; Shebrain, Abdulaziz; Al-Assil, Talal; Pacione, Sabrina C; Haj, Delour; Motan, Abdelrahman D; Momani, Faroog; Bzizi, Hanin; Jahromi, Bahar Saadaie; Lewis, Ramona Meraz; Steeg, Kyle Ver 2nd

Novel vs. modified platelet-rich plasma therapy for hair loss treatment: a systematic review and meta-analysis

新型与改良型富血小板血浆疗法治疗脱发:系统评价和荟萃分析

Fatima, Kaneez; Ovais, Haziq; Anwar, Zainab; Abdul Latif Motan, Maaz; Masood Khan, Maaz; Khowaja, Aly H; Shahriyar Ghazanfar, Altamash; Khalid, Muhammad A; Jamil, Ayesha; Ismail Mujtaba, Yahya; Kumar, Sahil; Rashid, Ahmed M

Assisted human reproduction and pregnancy outcomes in Alberta, 2009-2018: a population-based study

2009-2018年阿尔伯塔省辅助生殖和妊娠结局:一项基于人群的研究

Moore, Linn E; Haijhosseini, Morteza; Motan, Tarek; Kaul, Padma

Predicting acute ovarian failure in female survivors of childhood cancer: a cohort study in the Childhood Cancer Survivor Study (CCSS) and the St Jude Lifetime Cohort (SJLIFE)

预测儿童癌症女性幸存者急性卵巢功能衰竭:儿童癌症幸存者研究 (CCSS) 和圣裘德终生队列 (SJLIFE) 的队列研究

Clark, Rebecca A; Mostoufi-Moab, Sogol; Yasui, Yutaka; Vu, Ngoc Khanh; Sklar, Charles A; Motan, Tarek; Brooke, Russell J; Gibson, Todd M; Oeffinger, Kevin C; Howell, Rebecca M; Smith, Susan A; Lu, Zhe; Robison, Leslie L; Chemaitilly, Wassim; Hudson, Melissa M; Armstrong, Gregory T; Nathan, Paul C; Yuan, Yan

Mesenchymal stem cells and immunomodulation: current status and future prospects

间充质干细胞与免疫调节:现状与展望

Gao, F; Chiu, S M; Motan, D A L; Zhang, Z; Chen, L; Ji, H-L; Tse, H-F; Fu, Q-L; Lian, Q

Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer

一项随机、双盲研究,比较拟上市的生物类似药 LA-EP2006 与参考药物培非格司亭在乳腺癌治疗中的疗效

Harbeck, Nadia; Lipatov, Oleg; Frolova, Mona; Udovitsa, Dmitry; Topuzov, Eldar; Ganea-Motan, Doina Elena; Nakov, Roumen; Singh, Pritibha; Rudy, Anita; Blackwell, Kimberly

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

三功能抗体卡妥昔单抗治疗上皮癌引起的恶性腹水:一项前瞻性随机II/III期试验的结果

Heiss, Markus M; Murawa, Pawel; Koralewski, Piotr; Kutarska, Elzbieta; Kolesnik, Olena O; Ivanchenko, Vladimir V; Dudnichenko, Alexander S; Aleknaviciene, Birute; Razbadauskas, Arturas; Gore, Martin; Ganea-Motan, Elena; Ciuleanu, Tudor; Wimberger, Pauline; Schmittel, Alexander; Schmalfeldt, Barbara; Burges, Alexander; Bokemeyer, Carsten; Lindhofer, Horst; Lahr, Angelika; Parsons, Simon L

XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.

在接受多西他赛/阿霉素化疗的乳腺癌患者中,XM02 在减少第 1 个疗程中严重中性粒细胞减少症的持续时间和发热性中性粒细胞减少症的发生率方面优于安慰剂,与 Neupogen 疗效相当

del Giglio A, Eniu A, Ganea-Motan D, Topuzov E, Lubenau H